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Background: Atrial fibrillation (A-fib) is an increasingly diagnosed disorder. While some data point to worse outcome in A-fib patients with systolic 
heart failure (SHF) as opposed to those without SHF, no data is available on the prognostic value of diastolic heart failure (DHF) in patients with 
A-fib. The purpose of this study is to evaluate the prognostic value of DHF and SHF in patients with A-fib.
Methods: This nested case-control study consists of veterans with A-fib. VA electronic medical records from veterans were used to evaluate the 
presence or absence of A-fib, SHF, DHF, mortality and traditional risk factors. Cox regression survival analysis was employed to assess the risk of 
mortality in A-fib patients with DHF and SHF.
Results: The study population consisted of 2267 patients with A-fib (age 68±11 years, 95% male). During the median follow-up of 10 years, the 
death rate was 8.4%. Survival rate significantly decreased from 95.3% in A-fib without heart failure to 84.7% in A-fib with DHF to 73.3% in A-fib with 
SHF (p=0.0001). After adjustment for age, gender and conventional risk factors, the hazard ratio of death for DHF and SHF were 3.78 (95%CI 2.05-
6.86, p=0.001) and 8.08 (95%CI, 4.24-12.35, p=0.001) as compared to A-fib without heart failure, respectively.
Conclusions: In patients with A-fib, DHF and SHF add prognostic value independent of traditional risk factors.
